Radioisotopes Research Today is a free monthly online journal that collates and summarizes the latest research about Radioisotopes, including details on radioimmunotherapy, radionuclides, procedures, hazards.

Volume 4 (2008), Issue 7 (July)

1. The use of chelated radionuclide (samarium-153-ethylenediaminetetramethylenephosphonate) to modulate phenotype of tumor cells and enhance T cell-mediated killing.
   Clin Cancer Res, 14(13): 4241-9. [Abstract] [Full-text]
2. Radioiodination of 1-(2-deoxy-beta-D-ribofuranosyl)-2,4-difluoro-5-iodobenzene (dRFIB), a putative thymidine mimic nucleoside for cell proliferation studies.
   Appl Radiat Isot, 66(9): 1221-8. [Abstract] [Full-text]
3. Therapeutic radionuclides: biophysical and radiobiologic principles.
   Semin Nucl Med, 38(5): 358-66. [Abstract] [Full-text]
4. Risks to normal tissues from radionuclide therapy.
   Semin Nucl Med, 38(5): 347-57. [Abstract] [Full-text]
5. Kinetic modeling in support of radionuclide dose assessment.
   Semin Nucl Med, 38(5): 335-46. [Abstract] [Full-text]

© 2005-2010 Radioisotopes Research Today. All Rights Reserved.